SCHEMBL7320951

SCHEMBL7320951

CCC(C)OC(=O)C1=C(COC(N)=O)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 6/20 0.62
CYP3A4 P08684 6/20 0.62
CYP1A2 P05177 6/20 0.62
ABCB11 O95342 5/20 0.62
CYP2C19 P33261 5/20 0.62
TBXA2R P21731 4/20 0.62
SLC6A3 Q01959 4/20 0.62
ADRA1A P35348 4/20 0.62
ADORA3 P0DMS8 4/20 0.62
SCN5A Q14524 4/20 0.62
NR1I2 O75469 4/20 0.62
KDM4E B2RXH2 3/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
HSD17B10 Q99714 3/20 0.62
OPRK1 P41145 3/20 0.62
ABCB1 P08183 3/20 0.62
TSHR P16473 3/20 0.62
NPSR1 Q6W5P4 3/20 0.62
NR3C1 P04150 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lemildipine SCHEMBL29801339 0.92 CYP2C9 (0.62) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
Lemildipine SCHEMBL49443 0.92 CYP2C9 (0.62) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
Lemildipine SCHEMBL49442 0.92 CYP2C9 (0.62) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
SCHEMBL7330272 0.91 CYP2C9 (0.71) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
SCHEMBL7328156 0.89 CYP2C9 (0.78) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
SCHEMBL11450911 0.89 CYP2C9 (0.74) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
SCHEMBL7318977 0.86 CYP2C9 (0.68) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
SCHEMBL11038359 0.85 CYP2C9 (0.71) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
SCHEMBL7320948 0.85 CYP2C9 (0.66) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19
SCHEMBL9770423 0.84 CYP2C9 (0.62) CYP2C9CYP3A4CYP1A2ABCB11CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494923-A Method of ameliorating cerebral circulation BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-02-27 US disclosed
US-5444077-A Ameliorant of cerebral circulation and optical isomer of NB-818, processes for its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-22 US disclosed
EP-0311053-A2 Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP disclosed